Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scrapie "could be zoonotic"
sheep
Scientists say the zoonotic potential of scrapie should be reassessed.
Disease may be able to cross the species barrier, new research suggests

Scientists have discovered that scrapie - the neurodegenerative disease that affects sheep and goats - could be zoonotic.

Similar to bovine spongiform encephalopathy (BSE), or "mad cow disease", scrapie is caused by pathogen proteins called prions.

BSE has been linked to Creutzfeldt-Jakob disease in humans, but epidemiological studies have not previously been able to show a link between scrapie and human prion diseases.

Lead author Olivier Andreoletti from the French National Institute for Agricultural Research (INRA), said: "Risks of transmitting scrapie to humans were hitherto considered negligible because of the species barrier that naturally prevents prion propagation between species".

INRA scientists have now discovered, however, that certain pathogens responsible for scrapie are in fact able to cross this barrier.

Using rodent models, the team also found those pathogens able to cross the barrier were indistinguishable from the prions causing the sporadic form of CJD.

Writing in the journal Nature Communications this month, the authors of the research say the zoonotic potential of scrapie should be reassessed.

However, as CJD is rare - around one case per million per year - the authors stress that even if future studies find scrapie to be zoonotic, it is unlikely to present a major new threat to public health.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.